BIOT

Biotech Acquisition Company Class A Ordinary Shares
BIOT

Overview Fund Activity
Delisted

BIOT was delisted on the 2nd of February, 2023.

Back to rankings

51 hedge funds and large institutions have $121M invested in Biotech Acquisition Company Class A Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+23
Holders Change %
+82.14%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
10
Reduced
1
Closed
1
Calls
$86K
Puts
–
Net Calls
+$86K
Net Calls Change
+$86K

Top Buyers

1
LA
1
Linden Advisors
New York
$6.57M
2
SCM
2
Saba Capital Management
New York
$5.7M
3
PC
3
Periscope Capital
Ontario, Canada
$7.35M
4
DCM
4
DG Capital Management
New York
$4.35M
5
RCM
5
Radcliffe Capital Management
Pennsylvania
$3.93M

Top Sellers

1
KCM
1
Kingstown Capital Management
New York
$0
2
TCM
2
Tenor Capital Management
New York
$1.39M
Name Holding Trade Value Shares
Change 		Shares
Change %
KCM
51
Kingstown Capital Management
New York
– -$2.92M -300,000 Closed
1 2
3